COL6A1 and atherosclerosis: It is present in advanced lesions (52) and identified as a specific autoantigen in atherosclerosis associated with experimental autoimmunity (53), supporting the notion that chronic inflammatory conditions lead to the generation of self-reactive immune responses to COL6A1.